Effect of Consolidation with Allogeneic Hematopoietic Cell Transplant Versus No Consolidation in Patients with Non-Hodgkin Lymphomas Treated with Bispecific Antibodies
Giulia Losi(University of Pavia), Alberto Mussetti(Duran i Reynals Hospital), Eva Domingo‐Doménech, Marjolein van der Poel(Maastricht University), Carolina Martínez(Institut d'Investigació Biomédica de Bellvitge), Yasmina Serroukh(Erasmus MC), Stéfania Bramanti(Istituti di Ricovero e Cura a Carattere Scientifico), Eva González‐Barca(Institut Català d'Oncologia), Philippe Armand(Harvard University), Aitana Balaguer‐Roselló(Hospital Universitari i Politècnic La Fe), Nicole Fabbri(Institut Català d'Oncologia), Marta Peña(Institut Català d'Oncologia), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Ángel Serna(Vall d'Hebron Institut de Recerca), David Qualls(Memorial Sloan Kettering Cancer Center), Jennifer L. Crombie(Dana-Farber Cancer Institute), Ya‐Ting Hsu(National Cheng Kung University Hospital), Patricia López(Institut d'Investigació Biomédica de Bellvitge), Carolina Esther Arevalo Leon(Institut d'Investigació Biomédica de Bellvitge), Itziar Carro(Institut d'Investigació Biomédica de Bellvitge), Felipe Peña(Institut d'Investigació Biomédica de Bellvitge), Ana Jiménez Ubieto(Hospital Universitario 12 De Octubre), Christopher McKinnely(Fiona Stanley Hospital), Jacopo Mariotti(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 0
Related Papers
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
Ipilimumab for Patients with Relapse after Allogeneic Transplantation
|New England Journal of Medicine|2016|595
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|484
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468